The clinical trials landscape will continue evolving toward greater decentralization, enhance patient-centricity, and increased global diversification. Industry projections suggest that by 2025, ...

Ithaka Group's portfolio underperformed the Russell 1000 Growth Index by 700bps in Q4 2025. Read the full analysis of top ...